Gefapixant, a Novel P2X3 Antagonist, Protects against Post Myocardial Infarction Cardiac Dysfunction and Remodeling Via Suppressing NLRP3 Inflammasome

Yanzhao Wei(Wuhan University), Yanhong Tang(Wuhan University), Shuang Yang(Chongqing University), Wei Li(Fujian Medical University)
Current Medical Science
January 9, 2023
Cited by 7


Related Papers